Publications
- Regorafenib for metastatic colorectal cancer: An analysis of a registry-based cohort of 555 patients2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Safety and effectiveness of aflibercept + fluorouracil, leucovorin, and irinotecan (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) in current clinical practice: OZONE study2020 | Publication without faculty affiliation
- Regorafenib - role of the drug in the current real-life oncological practice2018 | Publication without faculty affiliation
- Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry2017 | First Faculty of Medicine
- Gastrointestinal stromal tumors - quantitative detection of the Ki-67, TPX2, TOP2A, and hTERT telomerase subunit mRNA levels to determine proliferation activity and a potential for aggressive biological behavior2016 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry2015 | First Faculty of Medicine
- Bevacizumab with chemotherapy in patients with KRAS wild-type metastatic colorectal cancer: Czech registry data2015 | Publication without faculty affiliation
- Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts2012 | Second Faculty of Medicine
- Preoperative radiotherapy for locally advanced rectal cancer and prognostic factors influencing outcome2006 | Second Faculty of Medicine
- Klinická onkologie2023 | Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...